Q2 2025 · 13F-HR
Trustees of Columbia University in the City of New Yorkholdings as filed
Filed 2025-08-14 · accession 0000904454-25-000424
$690.9M
Reported value
9
Positions
2025-06-30
Period end
The Brief · Trustees of Columbia University in the City of New York · Q2 2025
AI · grounded in 13F
Trustees of Columbia University in the City of New York established a new position in SPY valued at $687.4M. The fund also initiated new stakes in VIGL for $1.5M and HEI/A for $824.6K. Additional new positions include SRZN, QTTB, and TNYA.
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 78462F103 | SPY | SPDR S&P 500 ETF TR | $687.4M | 99.5% | 1,112,613 | Common | SOLE |
| 92673K108 | VIGL | VIGIL NEUROSCIENCE INC | $1.5M | 0.22% | 192,973 | Common | SOLE |
| 422806208 | HEI/A | HEICO CORP NEW | $824,636 | 0.12% | 3,187 | Common | SOLE |
| 86889P208 | SRZN | SURROZEN INC | $428,494 | 0.06% | 47,930 | Common | SOLE |
| 746964105 | QTTB | Q32 BIO INC | $199,515 | 0.03% | 133,903 | Common | SOLE |
| 87990A106 | TNYA | TENAYA THERAPEUTICS INC | $178,307 | 0.03% | 291,828 | Common | SOLE |
| 98422T100 | XLO | XILIO THERAPEUTICS INC | $169,752 | 0.02% | 249,635 | Common | SOLE |
| 929033108 | VOR | VOR BIOPHARMA INC | $148,894 | 0.02% | 91,910 | Common | SOLE |
| 86889P117 | SRZNW | SURROZEN INC | $600 | 0.00% | 33,333 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.